Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Dr. Reddy’s allowed to sell generic eszopiclone in US
BackBack

Dr. Reddy’s allowed to sell generic eszopiclone in US

Eszopiclone tablets are sold under the brand name Lunesta by US drugmaker Sunovion Pharmaceuticals

Lunesta had US sales of around $887 million in the 12 months to January, Dr.Reddy’s said in a statement. Photo: Bharath Sai/MintPremium
Lunesta had US sales of around $887 million in the 12 months to January, Dr.Reddy’s said in a statement. Photo: Bharath Sai/Mint

Hyderabad: Drugmaker Dr. Reddy’s Laboratories Ltd on Wednesday said it got approval from the US Food and Drug Administration (FDA) to sell its version of anti-insomnia drug eszopiclone in the US. Eszopiclone tablets are sold under the brand name Lunesta by US drugmaker Sunovion Pharmaceuticals Inc.

Lunesta had US sales of around $887 million in the 12 months to January, Dr.Reddy’s said in a statement, quoting US healthcare information provider IMS Health.

Mylan Inc. and Glenmark too have been allowed to launch eszopiclone along with Dr.Reddy’s.

Shares of Dr. Reddy’s fell 1.48% to Rs2,539.35 a unit on BSE on Wednesday, while the benchmark Sensex declined 0.92% to 22,277.23 points.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 16 Apr 2014, 07:11 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie